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Abstract 
The Effects of Vascular Endothelial Growth Factor on the Characteristics of 
Pluripotent Dental Pulp Stem Cells 
 
By 
 
Cale Forgues 
 
Dr. Karl Kingsley, Examination Committee Chair 
Associate Professor of Biomedical Sciences 
Director of Student Research 
University of Nevada, Las Vegas 
School of Dental Medicine 
 
  
 
Many believe that stem cells hold the key to regenerative medicine. Therefore, research 
with stem cells has become increasingly popular over the years. Three specific groups of study 
have become present in literature. The first group has focused much of their research on 
harvesting and cultivating stem cell lines to retain their pluripotent ability. Stem cells can be 
tricky to cultivate and preserve over time as they will often differentiate or die. Another group 
examines the specific characteristics that a pluripotent stem cell has and how to retain, or even 
create, a cell with pluripotent potential. Lastly, the third group aims to focus on the ability to 
differentiate stem cells down specific cell lineages for therapeutic use. This study will draw upon 
  iv 
the latter two focuses and examine the specific characteristics of stem cells when combined with 
a cytokine during cultivation. 
 Vascular endothelial growth factors (VEGF) are a family of growth factors known to play 
an important part in embryonic development of vascular formation as well as dental 
development. The processes of neovascularization, formation of new vessels in adults, is highly 
reliant on the presence of VEGF for both the activation and attraction of undifferentiated bone 
marrow derived mesenchymal stem cells (MSCs). While this is the case with bone marrow 
derived MSCs, few studies have shown the effects VEGF has on other adult stem cell lines, such 
as dental pulp stem cells (DPSC).  
 Dental pulp stem cells have only recently been discovered. Another source for pluripotent 
stem cells, DPSCs are easily harvested from avulsed or extracted teeth. Further studies hope to 
determine the versatility of DPSCs and find specific uses for them in regenerative therapies. 
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Chapter 1: Introduction 
Background and Significance 
 Having been only recently been discovered, dental pulp stem cells (DPSCs) may have the 
potential to revolutionize oral regenerative therapies. Dental pulp stem cells (DPSCs) are non-
embryonic, mesenchymal stem cells that are easily harvested, cultured, and maintained from 
extracted or avulsed teeth[1-3] For these reason DPSCs are ideal for studying the effects of 
growth factors on undifferentiated pluripotent cell lines. Being a stem cell with the ability to 
differentiation down any of the major embryonic stem cell lines, current studies are trying to 
determine which growth factors can be used to induce differentiation towards a desired cell 
lines.[4-5] One of these major growth factors known to be important to embryonic stem cell 
attraction and activation is vascular endothelial growth factor (VEGF).  
Vascular endothelial growth factor (VEGF) is a family of growth factors known to play 
an important part in vascular formation in early endothelial development as well as bone 
formation in dental development. [6-7] The majority of studies to date have examined how the 
family of VEGF ligands act on specific tyrosine kinase receptors to create intracellular responses 
in differentiated endothelial cells. The cellular responses, and intracellular effects of, VEGF on 
various lineages of multipotent DPSCs remains relatively unknown.[8-9]  
Research Question  
Based upon the limited amount of information regarding DPSC and in vitro 
differentiation, as well as the limited information regarding VEGF and the potential to 
differentiate DPSC – the main objective of this study was to screen evaluate the effects of VEGF 
on several DPSC isolates.  
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1. Is there an effect on characteristics of the DPSC lines when cultured with VEGF?  
 
Null (H0) hypothesis: There will be no effect on the characteristics of the DPSC isolates 
when cultured with VEGF  
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC 
isolates when cultured with VEGF  
 
2. Is there an effect on characteristics of the DPSC lines when cultured with VEGF in 
combination with BMP-2?  
 
Null (H0) hypothesis: There will be no effect on the characteristics of the DPSC isolates 
when cultured with VEGF in combination with BMP-2 
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC 
isolates when cultured with VEGF in combination with BMP-2 
Approval  
The protocol for this study was reviewed and approved by the Office for the Protection of 
Research Subjects (OPRS) and Institutional Review Board (IRB) OPRS#763012-1 
“Retrospective analysis of dental pulp stem cells (DPSC) from the University of Nevada Las 
Vegas (UNLV) School of Dental Medicine (SDM) pediatric and adult clinical population”. The 
original protocol for the collection and isolation of DPSC was approved by the IRB and 
OPRS#0907-3148 “Isolation of Non-Embryonic Stem Cells from Dental Pulp”.  
  
  3 
Research Design  
This retrospective study would involve the analysis of DPSCs previously isolated from 
clinical patients, recruited at random in the UNLV-SDM pediatric clinic. Eight cell lines will be 
used and replicated for three experimental trials (n=24). Cells will be cultured and propagated for 
ten passages to determine the rate of growth and doubling time (DT). Doubling time (DT) will be 
categorized as rapid or rDT (~2 days), intermediate or iDT (4-6 days), and slow or sDT (10-12 
days). To assess any changes to differentiation, total RNA will be isolated from each isolate 
using the Total RNA isolation reagent (TRIR) from Molecular Research Center (Cincinnati, OH) 
using the protocol recommended by the manufacturer. Screening for changes to mRNA 
expression in each DPSC isolated will be accomplished using the ABgene Reverse-iT One-Step 
RT-PCR protocol and reagent kit. Comparisons of the changes to viability or proliferation will 
be calculated and compared using two-tailed t-tests, which are appropriate for parametric data 
analysis. Due to the potential for Type I error, all analyses will be subsequently confirmed using 
analysis of variance or multiple (ANOVA).  
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Chapter 2 
Effects of vascular endothelial growth factor (VEGF) on dental pulp stem cells (DPSC) 
 
 
This chapter has been submitted for review and publication in the journal Current Research in 
Medicine and is presented in the style of that Journal. The complete Citation is:  
 
Forgues C, Kingsley K. Effects of vascular endothelial growth factor (VEGF) on dental pulp 
stem cells (DPSC). Journal of Current Research in Medicine 
 
 
Role of Authors: 
This work was carried out in collaboration between all authors. Author Cale Forgues and Eric 
Mullins were responsible for sample processing. Authors Dr. Karl Kingsley and Dr. Cale 
Forgues were responsible for project design, funding and manuscript preparation. All authors 
read and approved the final manuscript. 
 
Abstract 
Background: Dental pulp stem cells (DPSCs) are non-embryonic, mesenchymal stem 
cells that may have significant potential for therapeutic and regenerative biomedical applications. 
Studies of DPSC differentiation have demonstrated the potential to form many tissue types, 
including neural, osteogenic, and vascular precursors using cytokines and growth factors, such as 
vascular endothelial growth factor (VEGF). Methods: Eight previously isolated dental pulp stem 
cell (DPSC) isolates were grown in culture and treated with VEGF to evaluate any effects on 
growth, viability or biomarker expression. Results: Administration of VEGF at 10 ng/mL 
significantly inhibited growth in two rapidly dividing or rDT DPSC isolates, with no other 
measurable effects noted among the intermediate (iDT) or slow (sDT) growing DPSC isolates. In 
addition, VEGF administration of had no significant effects on viability of the sDT or iDT DPSC 
isolates, however, all three of the rapidly dividing or rDT DPSC isolates exhibited significantly 
increased viability. Finally, mRNA expression of osteogenic biomarkers alkaline phosphatase 
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(ALP) and Dentin sialophosphoprotein (DSPP) was observed among the rDT isolates with 
specific combinations of DPSC biomarkers expressed (NANOG in combination with Sox-2 or 
Oct-4 but not both). Conclusions: The results of these data suggest that VEGF administration 
may be sufficient to induce partial differentiation of DPSC isolates, although this may be 
dependent upon the MSC biomarker expression of the DPSCs. These preliminary data may 
further research into the potential for tissue regeneration and bioengineering. 
 
Key words: Dental pulp stem cell (DPSC), vascular endothelial growth factor (VEGF), cellular 
differentiation  
Introduction 
Dental pulp stem cells (DPSCs) are non-embryonic, mesenchymal stem cells than can be 
obtained, isolated, cultured, and cryopreserved with relative ease compared with other potential 
sources, which has driven recent scientific research into their potential for therapeutic 
applications [1-3]. Harvested from the dental pulp of primary teeth, extracted teeth, or avulsed 
teeth, DPSCs are multi-potent stem cells that may be useful to facilitate advanced regenerative 
therapies [4,5]. , These studies have provided a better overall understanding of the capabilities of 
mesenchymal stem cells (MSCs) and DPSCs, with recent evidence demonstrating that 
differentiation potential may depend, in part, on the tissue of origin used in MSC harvesting [6-
8].  
Studies done on DPSC differentiation have demonstrated the potential to form many 
tissue types, including neural, osteogenic, and vascular precursors [9-11]. Much progress has 
been made towards the in vitro and in vivo differentiation of DPSC towards specific cell lineages 
[12,13]. In fact, some evidence now suggests that individual growth factors, such as vascular 
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endothelial growth factor (VEGF), may be sufficient to induce partial differentiation of DPSC – 
although this may be more dependent upon specific biomarkers or DPSC characteristics [14-16]. 
It has been demonstrated that DPSCs can be stimulated using VEGF through the 
canonical Wnt-β-catenin pathway into differentiating into blood vessels that resembled 
embryonic vasculogenesis, revealing the importance of this growth factor (VEGF) in 
angiogenesis as well as its potential for regenerative vasculogenesis [11,12,16]. However, the 
majority of studies to date have examined how the family of VEGF ligands act on specific 
tyrosine kinase receptors to create intracellular responses in differentiated vascular endothelial 
cells, while the cellular responses to, and intracellular effects of, VEGF on various lineages of 
multipotent DPSCs remain relatively unknown [17].   
Differentiation potential and stem-ness may be linked with specific intracellular MSC 
biomarkers such as the expression of Sox-2, Oct-4 and NANOG, which have been found to be 
highly associated with the pluripotency of cells, including DPSC [18-20].  The presence or 
absence of these biomarkers in cultured DPSCs may determine the ability of the isolates to 
differentiate and self-replicate [21-23]. Based upon this understanding, the primary objective of 
this study was to evaluate the effects of VEGF on several DPSC isolates and to further evaluate 
the expression of specific biomarkers that may indicate pluripotency, as well as differentiation.    
Methodology 
Study approval 
The protocol for this study was reviewed and approved by the Office for the Protection of 
Research Subjects (OPRS) and Institutional Review Board (IRB) OPRS#763012-1 
“Retrospective analysis of dental pulp stem cells (DPSC) from the University of Nevada Las 
Vegas (UNLV) School of Dental Medicine (SDM) pediatric and adult clinical population”. The 
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original protocol for the collection and isolation of DPSC was approved by the IRB and 
OPRS#0907-3148 “Isolation of Non-Embryonic Stem Cells from Dental Pulp”.  
 
Study Design  
This retrospective study involved the analysis of DPSCs previously isolated from clinical 
patients, recruited at random the UNLV-SDM pediatric clinic.  Inclusion criteria included adult 
patients or pediatric patients aged seven (7) or older with their parents or guardian’s permission 
who agreed to participate and were scheduled for a tooth extraction of health (vital) intact teeth 
prior to the initiation of orthodontic treatment. Pediatric assent and Parental permission to 
consent for voluntary participation were obtained at the time of study enrollment. Exclusion 
criteria included any patient, parent or child that was not a patient of record at UNLV-SDM, any 
patient or guardian who declined to participate and any patients having teeth extracted due to 
injury (fracture), infection or other disease. 
 
DPSC Collection (initial) 
In brief, the overwhelming majority of patients who agreed to participate were scheduled 
for tooth extractions of third molars. Once extracted, each tooth was sectioned at the cemento-
enamel junction (CEJ) to allow extraction of the dental pulp with an endodontic broach for 
transfer into a sterile microcentrifuge tube containing 1X phosphate-buffered saline (PBS). 
Samples were stored on ice until transfer to a biomedical laboratory for processing and 
screening. To prevent research bias and prevent any patient identifying information from being 
disclosed, a randomly generated, non-duplicated number was assigned to each sample and 
concurrent patient demographic information collected. No patient-specific identifying 
information was subsequently available to any research team member. 
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Culture and Propagation 
Briefly, cells were cultured and propagated for ten passages to determine the rate of 
growth and doubling time (DT). Passage (or split) for each DPSC isolate was 1:2 and confluence 
determined with trypan blue and BioRad TC20 automated cell counter (Hercules, CA), using the 
manufacturer recommended protocol. Data collected included total and live cell number and the 
resulting percentage of viable cells for analysis. Doubling time (DT) was categorized as rapid or 
rDT (~2 days), intermediate or iDT (4-6 days), and slow or sDT (10-12 days). 
 
Experimental protocol 
To determine any effects on DPSCs, the cells were plated into 96-well tissue culture 
treated plates at a concentration of 1.2 x 104 cells/mL. Negative (non-treated) control cells were 
compared with cells treated with vascular endothelial growth factor (VEGF) from ThermoFisher 
Scientific (PCH9394) at a concentration of 10 ng/mL. Eight replicates were performed in each 
experiment for all DPSC isolates, which were repeated for a total of three experimental trials 
(n=24).  
 
RNA isolation 
To assess any changes to differentiation, total RNA was isolated from each isolate using 
the Total RNA isolation reagent (TRIR) from Molecular Research Center (Cincinnati, OH) using 
the protocol recommended by the manufacturer. RNA was subsequently screened for quality and 
quantity using ratio measurements of absorbance at 260 and 280 nm (A260/A280 ratio).  
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Polymerase chain reaction (PCR)  
Screening for changes to mRNA expression in each DPSC isolated was accomplished 
using the ABgene Reverse-iT One-Step RT-PCR protocol and reagent kit with specifications that 
included an initial reverse transcription at 47C for 30 minutes, followed by 30 cycles of 
denaturation at 95C for 10 minutes, annealing for 30 seconds at the appropriate temperature for 
each primer set, and final extension at 60C for one minute. Primers synthesize from Eurofins 
MWG Operon (Huntsville, AL) were: 
 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH); Annealing temperature 67C 
Forward primer-GAPDH, ATCTTCCAGGAGCGAGATCC; 20 nt, 55% GC, Tm 66C 
Reverse primer-GAPDH, ACCACTGACACGTTGGCAGT; 20 nt, 55% GC, Tm 70C 
Optimal temperature T(opt): Lower temperature – 5C = 61C 
 
Alkaline phosphatase (ALP); Annealing temperature: 72C 
Forward primer-ALP, CACTGCGGACCATTCCCACGTCTT;24 nt, 58% GC, Tm 74C 
Reverse primer- ALP, GCGCCTGGTAGTTGTTGTGAGCAT; 24 nt, 54% GC, Tm 72C 
Optimal temperature T(opt): Lower temperature – 5C = 67C 
 
Dentin sialophosphoprotein (DSPP); Annealing temperature: 68C 
Forward primer-DSPP, CAACCATAGAGAAAGCAAACGCG;23 nt, 48% GC, Tm 67C 
Reverse primer- DSPP, TTTCTGTTGCCACTGCTGGGAC; 22 nt, 55% GC, Tm 70C 
Optimal temperature T(opt): Lower temperature – 5C = 62C 
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Statistical analysis 
Basic proliferation and viability information regarding the DPSC isolated were compiled 
and presented using simple descriptive statistics (counts and percentages). Comparisons of 
change to viability or proliferation were calculated and compared using two-tailed t-tests, which 
are appropriate for parametric data analysis. Due to the potential for Type I error, all analyses 
were subsequently confirmed using analysis of variance or multiple (ANOVA).   
Results 
To determine any effects on DPSC phenotypes, vascular endothelial growth factor 
(VEGF) was administered in 96-well assays (Figure 1). These results demonstrated that the 
majority of DPSC isolates were not significantly affected by VEGF administration, p>0.05. 
However, two DPSC isolates (dpsc-3882, dpsc-5653) had significant measurable decreases in 
proliferation under VEGF administration, p=0.038 and p=0.041 respectively. In addition, dpsc-
3882 and dpsc-5653 were both categorized as having rapid doubling times or rDT. 
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Figure 1. Effects of VEGF administration on DPSC growth. Administration of VEGF at 10 
ng/mL had a significant effect on two rapidly dividing (rDT) DPSC isolates, dpsc-3882 and 
dpsc-5653 – which were significantly lower than the negative controls (p=0.038 and p=0.041, 
respectively). No other measurable effects were noted among the intermediate (iDT) or slow 
(sDT) DPSC isolates. 
 
 
To evaluate if the observed changes in proliferation and cellular growth correlated with 
any changes to other DPSC phenotypes, cellular viability was also measured under VEGF 
administration (Figure 2). Although no significant changes to viability were noted among the 
iDT or sDT DPSC isolates under VEGF administration, all three of the rDT DPSC isolates 
demonstrated significant measurable increases to viability over the 72 hour time course, p<0.05.  
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Figure 2. Effects of VEGF administration on DPSC viability. Administration of VEGF at 10 
ng/mL had no significant effects on the intermediate (iDT) or slow (sDT) DPSC isolates, p>0.05. 
However, all three of the rapidly dividing or rDT DPSC isolates, dpsc-3882, dpsc-5653, dpsc-
7089 exhibited increased viability (p=0.018, p=0.011, p=0.122, respectively).  
 
 
To determine if any of the changes to cellular growth or viability induced by VEGF 
administration among the DPSC isolates were associated with changes to DPSC biomarkers for 
osteoblastic differentiation, RT-PCR screening of RNA was performed (Figure 3). In brief, 
primers specific for alkaline phosphatase (ALP) and dentin sialophosphoprotein (DSPP) were 
used to screen for mRNA expression of these biomarkers. These results demonstrated that VEGF 
administration was sufficient to induce mRNA expression of ALP in two DPSC isolates (dpsc-
3882, dpsc-5653). In addition, VEGF administration was also sufficient to induce DSPP mRNA 
expression in one DPSC isolate (dpsc-3882). 
Cellular viability
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*
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Figure 3. DPSC osteogenic mRNA biomarker induction following VEGF treatment. VEGF 
administration (10 ng/mL) was sufficient to induce mRNA expression of alkaline phosphatase 
(ALP) in two rDT DPSC isolates (dpsc-3882, dpsc-5653) and dentin sialophosphoprotein 
(DSPP) mRNA expression in dpsc3882. Expression of these mRNA biomarkers were not evident 
in any of the other DPSC isolates. 
 
 
Finally, an evaluation of the MSC biomarkers for each DPSC isolate was performed to 
determine if there were any associations with VEGF responsiveness (Figure 4). This analysis 
revealed that MSC biomarkers Sox-2, Oct-4 and NANOG were differentially expressed by the 
DPSC isolates (Fig 4A). For example, the rDT DPSC isolates each had a distinct expression 
profile (dps-3882: Oct-4, NANOG; dpsc-5653: Sox-2, NANOG; dpsc-7089: Sox-2, Oct-4, 
rDT iDT sDT
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NANOG). In contrast, none of the iDT DPSC isolates expressed Oct-4, while none of sDT 
expressed either Sox-2 or Oct-4.   
When combined with the results of VEGF assay, these data demonstrated that only the 
rDT DPSC isolates that expressed a combination of NANOG with either Oct-4 or Sox-2 (but not 
both) were responsive to VEGF administration (Fig. 4B). More specifically, the rDT DPSC 
isolate expressing a combination of Oct-4 and NANOG exhibited the most robust VEGF 
response, producing both ALP and DSPP (dpsc-3882). The rDT DPSC isolate expressing the 
combination of Sox-2 and NANOG exhibited some response to VEGF, producing ALP but not 
DSPP (dpsc-5653). However, the rDT isolate that expressed all three MSC biomarkers (Sox-2, 
Oct-4, NANOG) did not exhibit an osteogenic response to VEGF administration – similar to the 
negative response of the iDT DPSC isolates (Sox-2, NANOG) and sDT DPSC isolates (NANOG 
only). 
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Figure 4. MSC mRNA biomarker analysis of DPSC isolates. Osteogenic VEGF response was 
observed in DPSC isolates expressing NANOG in combination with either Oct-4 (dpsc-3882) or 
Sox-2 (dpsc-5653) but not both (dpsc-7089). No osteogenic VEGF response was noted among 
the iDT (Sox-2, NANOG) or sDT (NANOG) DPSC isolates.  
 
Discussion 
Research that has evaluated DPSC differentiation has demonstrated the potential to form 
many cell types, including neural, osteogenic, and vascular precursors using cytokines and 
growth factors, such as vascular endothelial growth factor [11,12]. However, the phenotypic and 
cellular effects of VEGF on various lineages of multipotent DPSCs remains relatively unknown, 
therefore this study sought to evaluate these effects on several DPSC isolates with distinct 
markers of pluripotency[14-16]. The results of this study demonstrated that VEGF has distinct 
and specific effects on DPSC phenotypes, although these were not observed uniformly among all 
DPSC isolates. 
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For example, cellular growth and viability were markedly affected by VEGF only among 
the rapidly growing (rDT) DPSC isolates, which mirrors similar findings of VEGF effects on 
rapidly dividing MSC from other tissues [24-26]. In addition, VEGF appears to induce 
osteogenic biomarker expression in a subset of rDT DPSC isolates, a finding that appears to 
support observations of VEGF osteogenic effects in other MSCs [27-29].  To understand these 
observations more thoroughly, an analysis of MSC biomarker expression and the associations 
with osteogenic marker induction may be necessary [23,30,31].  
New evidence has suggested that MSC biomarker expression in DPSCs may determine, 
in part, their differentiation potential and responsiveness to external stimuli [32-34]. The results 
of this study support these findings, with observations that rapidly dividing DPSC isolates 
expressing NANOG in combination with either Sox-2 or Oct-4 were responsive to VEGF 
administration. This research may also provide a potential explanation for the observation that 
DPSC expression of Oct-4, Sox-2 and NANOG were not responsive to VEGF administration, 
noting that “stemness” and pluripotency are correlated with MSC biomarker expression and that 
DPSC expression of more MSC biomarkers may indicate more than one stimulus or induction 
factor may be needed to facilitate differentiation [35,36].  
Conclusions 
The results of these data suggest that VEGF administration may be sufficient to induce 
partial differentiation of DPSC isolates, although this may be dependent upon the MSC 
biomarker expression of the DPSCs. In addition, the phenotypic changes to these DPSC isolates 
(decreased growth, increased viability) support these observations and may preliminary data to 
further research into the potential for osteogenic differential of DPSC. This may contribute to the 
overall, long-term goals of DPSC use for tissue regeneration and bioengineering. 
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Chapter 3 
Effects of Vascular Endothelial Growth Factor (VEGF) alone and in combination on rapidly 
dividing Dental Pulp Stem Cells (DPSC) 
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Abstract 
Background: Dental pulp stem cells (DPSC) are known to possess many of the properties 
of pluripotent stem cells. Many researchers have focused their efforts to refine the range of 
growth factors that influence and modulate DPSC growth and differentiation. More specifically, 
some evidence has emerged that demonstrated Vascular Endothelial Growth Factor (VEGF) may 
be sufficient to enhance odontogenic and angiogenic potential of some DPSC isolates. Based 
upon this information, the primary objective of this study was to evaluate whether VEGF 
administration or concomitant VEGF and Bone Morphogenic Protein (BMP) administration 
induced any measurable effects on DPSCs.  
Methods: This study used six (n=6) previously isolated and characterized DPSCs, cells, 
which were sorted into rapid doubling time (rDT ~1-2 days, n=3) and intermediate doubling time 
(iDT ~4-6 days, n=3). Each DPSC isolate was plated into 96-well assay plates for three days 
using media with and without VEGF, BMP-2 alone and in combination. Cellular growth and 
viability were measured for comparison. 
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Results: Administration of VEGF reduced growth in two of the rDT DPSC isolates (dpsc-
3882,  dpsc-5653), with no effect on the iDT DPSC isolates (dpsc-8124, dpsc-9894, dpsc-
17322). A corresponding increase in cellular viability was noted among all the rDT DPSC 
isolates along with corresponding changes to cellular morphology, with no effect on the iDT 
DPSCs. BMP-2 exhibited no effects on either rDT or iDT DPSC isolates. The combination of 
VEGF and BMP-2 in combination had similar effects to the administration of VEGF in isolation.  
Discussion: These data provide significant preliminary results that clearly demonstrate 
significant and pronounced effects of VEGF on at least one subset of rapidly dividing DPSC 
isolates. These effects include changes to cellular viability and growth, which are supported by 
clear changes to cellular adhesion and morphology. However, these data strongly suggest more 
reseach is needed to determine the underlying pathways triggered by VEGF administration in the 
cells and the pathophysiologic mechanisms that determine the responsiveness of these DPSC 
isolates but not others.  
 
Key words: Dental Pulp Stem Cells (DSPC), Vascular Endothelial Growth Factor (VEGF). 
 
Background 
Dental pulp stem cells (DPSC) are known to possess many of the properties of 
pluripotent stem cells [1,2]. Recent studies have demonstrated that DPSCs may have therapeutic 
potential as multipotent stem cells with the capacity for reprogramming and bioengineering 
applications [3,4]. However, the ability to control and transform DPSC into specific lineages 
with precision and accuracy remains an elusive and motivating goal [5-7].  
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Many researchers have focused their efforts to refine the range of growth factors that 
influence and modulate DPSC growth and differentiation [8]. For example, some studies have 
demonstrated specific effects of fibroblast growth factor (FGF) as a transforming growth factor 
on DPSCs to facilitate odontoblast differentiation and dentin formation [9,10]. Others have 
focused attention on vascular endothelial growth factor (VEGF), which may play a critical role 
in DPSC regeneration, differentiation and pluripotency [11,12].  
More specifically, some evidence has emerged that demonstrated VEGF may be 
sufficient to enhance odontogenic and angiogenic potential of some DPSC isolates [13,14]. In 
fact, research from this group recently demonstrated VEGF may have the potential to induce 
osteogenic phenotypes in some subsets of DPSC – although these effects were not uniform or 
consistent and were mainly restricted to the most rapidly dividing DPSCs [15]. Alternatively, 
one recent study demonstrated that VEGF administration or temporal “priming” of DPSC with 
VEGF may enhance their odontogenic and osteogenic differentiation potential in combination 
with other growth factors, such as bone morphogenic protein (BMP) [16].  
Based upon this information, the primary objective of this study was to evaluate whether 
VEGF administration or concomitant VEGF and BMP administration induced any measurable 
effects on DPSCs.  
Material and Methods 
Protocol approval 
This study was approved through the Office for the Protection of Research Subjects 
(OPRS) and the Institutional Review Board (IRB) at the University of Nevada, Las Vegas 
(UNLV) under protocol OPRS#763012-1 “Retrospective analytsis of dental pulp stem cells 
(DPSC) from the UNLV School of Dental Medicine (SDM) pediatric and clinical population. 
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The DPSC isolates were originally collected and obtained under OPRS#0907-3148 “Isolation of 
Non-Embryonic Stem Cells from Dental Pulp”. Each DPSC isolate was given a unique 
identifying number to prevent bias and disallow any patient identifying information from being 
disclosed. 
 
DPSC culture 
All DPSC isolates were originally cultured for a minimum of ten (10) passages to 
ascertain the rate of growth or doubling time (DT). The average time between passaging for each 
DPSC isolate was characterized as either rapid doubling time (rDT) between 0-2 days and 
intermediate doubling time (iDT) between 4-6 days. All cells were maintained in Roswell Park 
Memorial Institute (RPMI) 1640 Medium with the addition of 10% Fetal Bovine Serum (FBS) 
and 1% Penicillin-Streptocmycin from Fisher Scientific. Cells were maintained in 25 cm2 tissue 
culture flasks at 5% CO2 in humidified tissue culture chambers.  
 
Experimental growth factors 
The previous study from this group determined that only rapdily dividing or rDT DPSC 
isolates responded to VEGF administration, therefore - to determine any effects on DPSC 
isolates, rDT DPSC isolates were plated into 96-well assay plates for three days using media 
with and without additional growth factors. An additional set of experiments with intermediate or 
iDT DPSC isolates was used for comparison. Vascular Endothelial Growth Factor (VEGF) 
obtained from Fisher Scientific (PCH9394) was used at an experimental concentration of 10 
ng/mL and Bone Morphogenic Protein (BMP-2) from Fisher Scientific (RP-8638) at a similar 
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concentration of 10 ng/mL. Cells were either plated without any growth factor as a negative 
control (CTL), with VEGF, BMP-2 or both VEGF and BMP-2 concomitantly.  
 
Proliferation and Viability 
Cells were grown for three days in each experimental condition (n=24 wells/plate) and 
each experiment was replicated in triplicate. Experimental assays were fixed with 10% buffered 
formalin for 24 hours. Following fixation, cells were stained with Gentian Violet and absorbance 
(growth) measured using a BioTek 808x 96-well plate reader. Higher absorbance readings 
correspond with higher growth measurements and larger cell numbers, as previously described 
[17,18]. Viability was measured using the Trypan Blue exclusion assay and a BioRad TC20 
automated cell counter, as previously described [19,20]. Cells were imaged at 20X using an 
AxioVert inverted microscope from Ziess.  
 
Statistical analysis 
As continuous (parametric) data measurements were made using absorbance readings at 
630 nm, differences between experimental and control treatments were evaluated using two-
tailed t-tests. An alpha level of a=0.05 was used to determine statistical significance.  
Results 
The results of the initial experimental assay using rapidly dividing or rDT DPSC isolates 
demonstrated that two DPSC isolates responded to VEGF administration (Figure 1). More 
specifically, VEGF administration induced significant, measurable decreases in cellular growth 
among dpsc-3882 (-39.1%, p=0.018) and dpsc-5653 (-12.6%, p=0.039) over three days 
compared with the negative control – with no measurable differences observed among dpsc-7089 
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(-4.3%, p=0.852). In contrast, administration of BMP-2 did not significantly alter cellular growth 
among any of the rDT DPSC isolates, including dpsc-3882 (-2.5%, p=0.948), dpsc-5653 (+2.4%, 
p=0.823), and dpsc-7089 (-7.2%, p=0.742). However, concomitant administration of VEGF in 
combination with BMP-2 appeared to have a more modest effect on rDT DPSC isolates, 
reducing growth in dpsc-3882 (-33.3%, p=0.0241), dpsc-5653 (-6.7%, p=0.592), and dpsc-7089 
(-5.8%, p=0.691).  
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Figure 1. Growth factor effects on rapidly dividing (rDT) DPSC isolates. Administration of 
VEGF reduced growth in dpsc-3882 and dpsc-5653 significantly (-39.1%, p=0.018; -12.6%, 
p=0.039) with no effect on dpsc-7089 (-4.3%, p=0.852). Administration of BMP-2 alone 
exhibited no significant effects on growth in rDT DPSC isolates, although VEGF-BMP-2 in 
combination had a modest effect on dpsc-3882 (-33.3%, p=0.0241). 
 
 
The results of the subsequent experimental assay using intermediate dividing or iDT 
DPSC isolates demonstrated no significant or measurable effects on these DPSC isolates (Figure 
2). More specifically, the administration of VEGF did not exhibit any significant effect on 
cellular growth in any of the iDT DPSC isolates, including dpsc-8124 (-3.3%, p=0.137), dpsc-
9894 (+1.3%, p=0.539), and dpsc-17322 (+3.1%, p=0.165). The concomitant administration of 
VEGF and BMP-2 also had no significant effect on cellular growth in dpsc-8124 (-8.1%, 
p=0.0579), dpsc-9894 (-4.2%, p=0.441), and dpsc-17322 (-0.8%, p=0.887). These results were 
similar to the observations with the administration of BMP-2 on dpsc-8124 (-3.6%, p=0.189), 
dpsc-9894 (+0.5%, p=0.653), and dpsc-17322 (-1.3%, p=0.794).   
  32 
 
Figure 2. Growth factor effects on intermediate dividing (iDT) DPSC isolates. Administration of 
VEGF exhibited no significant effect on iDT DPSC growth: dpsc-8124 (-3.3%, p=0.137), dpsc-
9894 (+1.3%, p=0.539), and dpsc-17322 (+3.1%, p=0.165) – similar to the effects of BMP-2: 
dpsc-8124 (-3.6%, p=0.189), dpsc-9894 (+0.5%, p=0.653), dpsc-17322 (-1.3%, p=0.794). 
Combined VEGF and BMP-2 also had no significant effects: dpsc-8124 (-8.1%, p=0.0579), 
dpsc-9894 (-4.2%, p=0.441), dpsc-17322 (-0.8%, p=0.887).  
 
 
To evaluate whether any of the observations in cellular growth were associated with any 
changes to survival, cellular viability was evaluated under each control and experimental 
condition (Figure 3). These data demonstrated an overall higher viability for the iDT DPSC 
isolates at baseline: dpsc-8124 (34%), dpsc-9894 (33%), dpsc-17322 (36%) compared with the 
rDT DPSC isolates: dpsc-3882 (21%), dpsc-5653 (23%), dpsc-7089 (22%), which was 
statistically significant, p=0.0067.  
The addition of VEGF significantly increased cellular viability among the rDT DPSC 
isolates, such as dpsc-3882 (35%, +61.9%), dpsc-5653 (35%, +52.1%), and dpsc-7089 (32%, 
+45.4%), p=0.0081. However, no corresponding increase in viability was observed in any iDT 
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DSPC isolate under , including dpsc-8124 (37%, +5.4%), dpsc-9894 (36%, +5.8%), and dpsc-
17322 (39%, +8.3%), p=0.102. 
However, the addition of BMP-2 did not significantly alter cellular viabilty among the 
rDT DPSC isolates, inclduing dpsc-3882 (20%, -4.7%), dpsc-5653 (22%, -4.3%), and dpsc-7089 
(21%, -4.5%), p=0.287. Similarly, no effects were observed among the iDT DPSC isolates, such 
as dpsc-8124 (35%, no change), dpsc-9894 (31%, -8.8%), and dpsc-17322 (33%, -8.3%), 
p=0.221.  
The concomitant administration of VEGF and BMP-2 exhibited some effects on rDT but 
not iDT cellular viability. More specifically, VEGF-BMP-2 significantly increased viability 
among the rDT DPSC isolates, dpsc-3882 (35%, +66.7%), dpsc-5653 (33%, +43.4%), and dpsc-
7089 (31%, +40.9%), p=0.0036. In contrast, viability among the iDT DPSC isolates was not 
significantly changed under VEGF-BMP-2 administration, dpsc-8124 (36%, 2.8%), dpsc-9894 
(34%, no change), dpsc-17322 (37%, +2.7%), p=0.566 
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Figure 3. Growth factor effects on DPSC cellular viability.  The addition of VEGF (alone or in 
combination) significantly increased viabilty among the rDT DPSC isolates (dpsc-3882, dpsc-
5653, dpsc-8124) but had no effects on the iDT DPSC isolates (dpsc-8124, dpsc-9894, dpsc-
17322). No changes in cellular viability were observed with the administration of BMP-2 in 
either the rDT or iDT DPSC isolates. 
 
 
Microscopy was performed to more closely evaluate the effects of VEGF on growth and 
viability of the rDT DPSC isolates (Figure 4). This analysis revealed that the increases in cellular 
viability and decrease in growth were associated with significant changes to cellular morphology 
in both dpsc-3882 (Fig. 1A, Fig. 1D) and dpsc-5653 (Fig. 1B, Fig. 1E). It was also noted that 
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significant cell adhesion, cell spreading and increased cellular size was noted – although fewer 
overall numbers of cells were present. In addition, dpsc-7089 also contained a smaller proportion 
of cells with changes to adhesion, spreading and increased size (Fig. 1C, Fig. 1F). No changes to 
cell number, size or shape were noted among the iDT DPSC isolates (data not shown).  
 
 
 
Figure 4. Cellular morphology of rDT DPSC isolates in control and experimental conditions. The 
cellular morphology of rDT dpsc-3882 (A), dpsc-5653 (B), and dpsc-7089 (C) was marked 
altered by the addition of VEGF (D-F). Although an overall decrease in cell number was 
observed in dpsc-3882 and dpsc-5653 (D,E), an overall increase in cell size, cellular adherence 
and cell spreading was observed. No changes were observed with BMP-2 (G-I). 
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Discussion 
The main objective of this study was to evaluate whether VEGF administration or 
concomitant VEGF and BMP administration induced any measurable effects on DPSCs. These 
results demonstrated that administration of VEGF was sufficient to reduce growth in two of the 
rDT DPSC isolates, with no effect on any of the iDT DPSC isolates. Moreover, a corresponding 
increase in cellular viability was noted among all the rDT DPSC isolates along with 
corresponding changes to cellular morphology, with no effect on the iDT DPSCs. These results 
were in stark contrast to the effects of BMP-2, which exhibited no effects on either rDT or iDT 
DPSC isolates. In addition, the combination of VEGF and BMP-2 in combination had similar 
effects to the administration of VEGF in isolation, which may suggest VEGF may be primarily 
responsible for the observed changes to cellular phenotypes. 
Although these data strongly suggest that VEGF may alter rDT cellular phenotypes, such 
as viability, proliferation and morphology, the limited scope of this study was not sufficient to 
allow for the elucidation of specific pathways responsible for these effects. The limited evidence 
that exists for MSC has recently suggested that VEGF may act on mesencymal stem cells 
through ERK- and FAK-dependent mechanisms that increase cellular migration – although there 
is no evidence to suggest these same pathways may be active among the rDT DPSC isolates 
[21,22].  
The few studies that have explored VEGF in MSC or DPSC have been mainly restricted 
to studies of vasculogenic differentiation, an important topic for bioengineering and therapeutic 
applications [23, 24]. However, the potential for VEGF to induce other cellular phenotypes and 
differentiation into lineages other than angiogenic and endothelial lineages remains an exciting 
and potentially revolutionary application for stem cell therapy [25,26]. 
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Conclusions 
These data provide significant preliminary results that clearly demonstrate significant and 
pronounced effects of VEGF on at least one subset of rapidly dividing DPSC isolates. These 
effects include changes to cellular viability and growth, which are supported by clear changes to 
cellular adhesion and morphology. Taken together, these data strongly suggest more reseach is 
needed to determine the underlying pathways triggered by VEGF administration in the cells and 
the pathophysiologic mechanisms that determine the responsiveness of these DPSC isolates but 
not others.  
 
Competing Interests 
The authors declare that there are no conflicts of interest. 
  
  38 
References 
1. Morotomi T, Washio A, Kitamura C. Current and future options for dental pulp therapy. Jpn 
Dent Sci Rev. 2019 Nov;55(1):5-11. doi: 10.1016/j.jdsr.2018.09.001. Epub 2018 Sep 29. 
Review. PMID: 30733839  
2. Mendi A, Ulutürk H, Ataç MS, Yılmaz D. Stem Cells for the Oromaxillofacial Area: Could 
they be a promising source for regeneration in dentistry? Adv Exp Med Biol. 2019 Feb 7. doi: 
10.1007/5584_2018_327. [Epub ahead of print] PMID: 30725365 
3. Soda M, Saitoh I, Murakami T, Inada E, Iwase Y, Noguchi H, Shibasaki S, Kurosawa M, 
Sawami T, Terunuma M, Kubota N, Terao Y, Ohshima H, Hayasaki H, Sato M. Repeated human 
deciduous tooth-derived dental pulp cell reprogramming factor transfection yields multipotent 
intermediate cells with enhanced iPS cell formation capability. Sci Rep. 2019 Feb 6;9(1):1490. 
doi: 10.1038/s41598-018-37291-2. PMID: 30728386 
4. Monterubbianesi R, Bencun M, Pagella P, Woloszyk A, Orsini G, Mitsiadis TA. A 
comparative in vitro study of the osteogenic and adipogenic potential of human dental pulp stem 
cells, gingival fibroblasts and foreskin fibroblasts. Sci Rep. 2019 Feb 11;9(1):1761. doi: 
10.1038/s41598-018-37981-x. PMID: 30741963 
5. Anitua E, Zalduendo M, Troya M. Autologous plasma rich in growth factors technology for 
isolation and ex vivo expansion of human dental pulp stem cells for clinical translation. Regen 
Med. 2019 Feb 15. doi: 10.2217/rme-2018-0066. [Epub ahead of print] PMID: 30767653 
6. Bordin A, Pagano F, Scaccia E, Saccucci M, Vozza I, Incerti N, Polimeni A, Cavarretta E, 
Chimenti I, De Falco E. Oral Plaque from Type 2 Diabetic Patients Reduces the Clonogenic 
Capacity of Dental Pulp-Derived Mesenchymal Stem Cells. Stem Cells Int. 2019 Jan 
14;2019:1516746. doi: 10.1155/2019/1516746. eCollection 2019. PMID: 30755774 
  39 
7. Meza G, Urrejola D, Saint Jean N, Inostroza C, López V, Khoury M, Brizuela C. Personalized 
Cell Therapy for Pulpitis Using Autologous Dental Pulp Stem Cells and Leukocyte Platelet-rich 
Fibrin: A Case Report. J Endod. 2019 Feb;45(2):144-149. doi: 10.1016/j.joen.2018.11.009. 
PMID: 30711169 
8. Jin R, Song G, Chai J, Gou X, Yuan G, Chen Z. Effects of concentrated growth factor on 
proliferation, migration, and differentiation of human dental pulp stem cells in vitro. J Tissue 
Eng. 2018 Dec 21;9:2041731418817505. doi: 10.1177/2041731418817505. eCollection 2018 
Jan-Dec. PMID: 30622693 
9. Yokoi M, Kuremoto KI, Okada S, Sasaki M, Tsuga K. Effect of attenuation of fibroblast 
growth factor receptor 2b signaling on odontoblast differentiation and dentin formation. In Vitro 
Cell Dev Biol Anim. 2019 Feb 12. doi: 10.1007/s11626-019-00323-w. [Epub ahead of print] 
PMID: 30756235 
10. Salkın H, Gönen ZB, Ergen E, Bahar D, Çetin M. Effects of TGF-β1 Overexpression on 
Biological Characteristics of Human Dental Pulp-derived Mesenchymal Stromal Cells. Int J 
Stem Cells. 2018 Dec 31. doi: 10.15283/ijsc18051. [Epub ahead of print] PMID: 30595006 
11. Zhu L, Dissanayaka WL, Zhang C. Dental pulp stem cells overexpressing stromal-derived 
factor-1α and vascular endothelial growth factor in dental pulp regeneration. Clin Oral Investig. 
2018 Oct 12. doi: 10.1007/s00784-018-2699-0. [Epub ahead of print] PMID: 30315421 
12. Xue D, Gong Z, Zhu F, Qiu Y, Li X. Simvastatin increases cell viability and suppresses the 
expression of cytokines and vascular endothelial growth factor in inflamed human dental pulp 
stem cells in vitro. Adv Clin Exp Med. 2018 Aug 8. doi: 10.17219/acem/75776. [Epub ahead of 
print] PMID: 30088351 
  40 
13. Aksel H, Öztürk Ş, Serper A, Ulubayram K. VEGF/BMP-2 loaded three-dimensional model 
for enhanced angiogenic and odontogenic potential of dental pulp stem cells. Int Endod J. 2018 
Apr;51(4):420-430. doi: 10.1111/iej.12869. Epub 2017 Nov 14. PMID: 29080346 
14. Zhang M, Jiang F, Zhang X, Wang S, Jin Y, Zhang W, Jiang X. The Effects of Platelet-
Derived Growth Factor-BB on Human Dental Pulp Stem Cells Mediated Dentin-Pulp Complex 
Regeneration. Stem Cells Transl Med. 2017 Dec;6(12):2126-2134. doi: 10.1002/sctm.17-0033. 
Epub 2017 Oct 24. PMID: 29064632 
15. Forgues C, Mullins E, Kingsley K. Effects of vascular endothelial growth factor (VEGF) on 
dental pulp stem cells (DPSC). Curr Res Med. 2019, In review. 
16. Aksel H, Huang GT. Combined Effects of Vascular Endothelial Growth Factor and Bone 
Morphogenetic Protein 2 on Odonto/Osteogenic Differentiation of Human Dental Pulp Stem 
Cells In Vitro. J Endod. 2017 Jun;43(6):930-935. doi: 10.1016/j.joen.2017.01.036. Epub 2017 
Apr 27. PMID: 28457634 
17. Saarem W, Wang FY, Kingsley K, Farfel E. Propolis or Caffeic acid phenethyl ester (CAPE) 
inhibits growth and viability in multiple oral cancer cell lines. International Journal of Medical 
and Biomedical Studies (Int J Med Biomed) 2019, 3(1): 50-55. 
18. Whiting M, Kingsley K. Expression of microRNA among dental pulp stem cell (DPSC) 
isolates. Current Research in Dentistry, 2019. [Online first]. 
19. Agari K, Lin W, Kingsley K. Folic Acid-Modulated Growth of Dental Pulp Stem Cells 
(DPSCs). J Med Discov (2018); 3(3):jmd18024. DOI: 10.24262/jmd.3.3.18024  
20. Cinelli J, Ngueyn E, Kingsley K. Assessment of dental pulp stem cell (DPSC) biomarkers 
following induction with bone morphogenic protein (BMP-2). Journal of Advances in Biology 
and Biotechnology, 2018, 19(2): 1-12. Doi:10.9734/JABB/2018/44215 
  41 
21. Ishii M, Takahashi M, Murakami J, Yanagisawa T, Nishimura M. Vascular endothelial 
growth factor-C promotes human mesenchymal stem cell migration via an ERK-and FAK-
dependent mechanism. Mol Cell Biochem. 2018 Nov 15. doi: 10.1007/s11010-018-3481-y. 
[Epub ahead of print] PMID: 30443854 
22. Botero TM, Son JS, Vodopyanov D, Hasegawa M, Shelburne CE, Nör JE. MAPK signaling 
is required for LPS-induced VEGF in pulp stem cells. J Dent Res. 2010 Mar;89(3):264-9. doi: 
10.1177/0022034509357556. Epub 2010 Jan 28. PMID: 20110511 
23. Silva GO, Zhang Z, Cucco C, Oh M, Camargo CHR, Nör JE. Lipoprotein Receptor-related 
Protein 6 Signaling is Necessary for Vasculogenic Differentiation of Human Dental Pulp Stem 
Cells. J Endod. 2017 Sep;43(9S):S25-S30. doi: 10.1016/j.joen.2017.06.006. Epub 2017 Aug 1. 
PMID: 28778505  
24. Zhang Z, Nör F, Oh M, Cucco C, Shi S, Nör JE. Wnt/β-Catenin Signaling Determines the 
Vasculogenic Fate of Postnatal Mesenchymal Stem Cells. Stem Cells. 2016 Jun;34(6):1576-87. 
doi: 10.1002/stem.2334. Epub 2016 Mar 11. PMID: 26866635 
25. Villatoro AJ, Alcoholado C, Martín-Astorga MC, Fernández V, Cifuentes M, Becerra J.  
Comparative analysis and characterization of soluble factors and exosomes from cultured 
adipose tissue and bone marrow mesenchymal stem cells in canine species. Vet Immunol 
Immunopathol. 2019 Feb;208:6-15. doi: 10.1016/j.vetimm.2018.12.003. Epub 2018 Dec 18. 
PMID: 30712794 
26. Lee H, Lee H, Na CB, Park JB. The effects of simvastatin on cellular viability, stemness and 
osteogenic differentiation using 3-dimensional cultures of stem cells and osteoblast-like cells. 
Adv Clin Exp Med. 2019 Feb 5. doi: 10.17219/acem/94162. [Epub ahead of print] PMID: 
30729760 
  42 
Chapter 4: Summary and Conclusions 
The two studies presented provide further insight into the effects of vascular endothelial 
growth factor (VEGF) on the characteristics of pluripotent dental pulp stem cells (DPSC). It was 
the hope that the presence of VEGF would induce differentiation in cultured DPSCs showing a 
change in their presenting characteristics and intracellular mRNA biomarker expression.  
Chapter 2 of this paper delivered the results of a retrospective study that sought to 
determine if the presence of VEGF alone with DPSCs would have any effect on their 
characteristics. Eight cell lines were cultured for ten rounds to determine their doubling times. 
Doubling time (DT) was categorized as rapid or rDT (~2 days), intermediate or iDT (4-6 days), 
and slow or sDT (10-12 days). These categories were then used to help analyze the data 
collected. The results of this study revealed that two specific rDT isolates (dpsc-3882, dpsc-
5653) showed a significant measurable change in their growth when VEGF was administered 
(p=0.038 and p=0.041). No significant changes in growth were seen with any of the iDT or sDT 
isolates. When evaluating viability, the same two rDT isolates showed a statistically significant 
change (p=0.018 and p=0.011). Primer screening specific for alkaline phosphatase (ALP) and 
dentin sialophosphoprotein (DSPP) revealed rDT isolate dpsc-3882 to be expressing both DSPP 
and ALP, and rDT isolate dpsc-5653 to be only expressing ALP mRNA. Lastly, this study found 
that only the rDT group expressed a combination of NANOG with either Oct-4 or Sox-2. These 
rDT cell lines were the cell lines that showed significant change in both the growth and viability 
tests. 
Chapter 3 presented the study done on the comparison of DPSC characteristics when 
cultured with VEGF alone, bone morphogenic protein-2 (BMP-2) alone, and when cultured with 
a combination of both VEGF and BMP-2. The rDT and iDT DPSC isolates were used in this 
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study. Growth and viability were studied and measured for comparison. The results showed that 
the rDT isolates had significantly decreased growth when only VEGF was present, however, 
when BMP-2 and VEGF were administered in combination the effect on growth was more 
moderate. No significant affect was seen on growth when just BMP-2 was cultured with rDT 
DPSCs. Additionally, no significant change was seen on growth in any of the iDT samples. 
When evaluating viability, the addition of VEGF alone was seen to have a statistically significant 
effect on rDT isolates and no effect on iDT isolates. BMP-2 also did not alter the viability in 
either the rDT or iDT groups. The combination of VEGF and BMP-2 was seen to have the same 
significant effect on viability that VEGF alone did in the rDT group. No change was seen in the 
iDT combination group. Cellular microscopy from this study noted cell morphology changes in 
dpsc-3882 and dpsc-5653 isolates. Cell adhesions, cell spreading and an increased cellular size 
was noted. 
 
Based on the findings in each study, both alternative hypotheses can be accepted.  
 
1. Is there an effect on characteristics of the DPSC lines when cultured with VEGF?  
 
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC 
isolates when cultured with VEGF  
 
2. Is there an effect on characteristics of the DPSC lines when cultured with VEGF in 
combination with BMP-2?  
 
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC 
isolates when cultured with VEGF in combination with BMP-2 
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Limitations and Recommendations 
A significant limitation in the two studies presented is the number of DPSC cell lines 
available. Since DPSC collecting is only being done every couple of years, it has not been 
possible to maintain numerous cell lines. Funding for additional collection, as well as the 
purchase of standard cell lines, would help to expand the breadth of the study and allow for more 
standardized study. With the results from this study, different rDT cell lines would allow for 
follow-up studies to assist in determining the specific requirements for a reaction to VEGF.  
A follow-up study on different concentrations of VEGF and BMP-2 would provide more 
insight into the relationship that the two cytokines have on DPSCs. It would ultimately help to 
determine whether there is a competitive or noncompetitive interaction that is affecting the 
characteristics of DPSCs. 
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